VarmX announced its partnership with CSL, supporting the development of its lead asset VMX-C001, along with entering into an ...

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data from the Phase 2b ANTHEM-UC study with icotrokinra in ulcerative colitis will be the focus of a brief oral ...

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid cancers in combination with other immunotherapiesCancer Research UK’s ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

BNB surges past $900 to $920 following Franklin Templeton partnership. Strong institutional demand and market momentum hint ...

When design environments function seamlessly, engineers spend time engineering instead of wrestling with files or tools.

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

The U.S. military’s technical engineers begin their careers at Fort Leonard Wood during advanced individual training to learn ...

BSIF launches Bima Sugam website, a step towards digital insurance marketplace, aiming to enhance transparency and accessibility in India.

However, now, experience is the only differtiator; it’s not just about usability, it’s about how deeply a product understands ...

Phase 2 TOIVA trial successfully met recruitment target, enrolling 16 subjects at leading vascular anomaly centers; top-line data expected in mid-December 2025 Venous malformations are the most common ...

China’s CNNC has made its first major carbon-14 isotope export, boosting its role in the global nuclear medicine market.